UT v. Boston Scientific (Fed. Cir., July 27, 2026) 2024-2062

This episode concerns a judicial opinion from the United States Court of Appeals for the Federal Circuit regarding a patent dispute between the University of Texas (UT) and Boston Scientific Corporation (BSC). The conflict centers on UT’s ’296 patent, which covers a biodegradable polymer fiber designed for controlled drug delivery in medical implants like stents. While a lower court jury initially found that BSC infringed the patent and awarded damages, the appellate court reversed that decision entirely. The judges concluded that the patent is invalid because it was anticipatedby an older patent, referred to as Song, which already disclosed the same technology. Additionally, the court ruled that BSC did not infringe because their stent coating does not meet the legal definition of a "thread-like" fiber. Consequently, the court entered judgment in favor of Boston Scientific, nullifying the previous jury verdict and damage award.

This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.